PDT Partners’s Insmed INSM Stock Holding History

PDT Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-31,521	Closed	-$665K	–	632
2023 Q2	$665K	Buy	31,521 +10,316	+49%	+$196K	0.09%	336
2023 Q1	$362K	Sell	21,205 -12,185	-36%	-$237K	0.05%	431
2022 Q4	$667K	Sell	33,390 -55,307	-62%	-$1.07M	0.11%	333
2022 Q3	$1.91M	Buy	+88,697	New	+$2.13M	0.29%	79
2022 Q2	–	Sell	-28,601	Closed	-$672K	–	1047
2022 Q1	$672K	Buy	+28,601	New	+$665K	0.06%	496
2016 Q1	–	Sell	-42,403	Closed	-$770K	–	580
2015 Q4	$770K	Buy	42,403 +558	+1%	+$9.83K	0.11%	236
2015 Q3	$777K	Buy	41,845 +22,737	+119%	+$568K	0.02%	782
2015 Q2	$467K	Buy	+19,108	New	+$434K	0.01%	995
2014 Q4	–	Sell	-16,504	Closed	-$215K	–	852
2014 Q3	$215K	Buy	+16,504	New	+$249K	0.01%	1172
2013 Q4	–	Sell	-59,193	Closed	-$924K	–	881
2013 Q3	$924K	Buy	+59,193	New	+$752K	0.03%	796

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

PDT Partners's INSM Position: Q3 2023 in Review

PDT Partners sold out of Insmed (INSM) in Q3 2023, closing a stake of 31,521 shares — an estimated $665K sold.

PDT Partners first reported a position in INSM in Q3 2013 and held it in 10 quarters. The position peaked at $1.91M in Q3 2022. 252 funds tracked by Wall St. Rank hold INSM as of Q3 2023.

PDT Partners reported no remaining Insmed position as of Q3 2023 after selling out during the quarter.
PDT Partners sold 31,521 Insmed shares in Q3 2023, an estimated $665K.
PDT Partners first reported a position in Insmed in Q3 2013 and held it in 10 quarters.
PDT Partners's Insmed position peaked at $1.91M in Q3 2022.
252 funds tracked by Wall St. Rank held Insmed as of Q3 2023.

Based on PDT Partners's 13F filing for Q3 2023, filed 14 Nov 2023.